Landmark Cannabis Trial May Give NSW Cancer Patients 'The Capacity To Fight'

Tilray, a global provider of medical cannabis which conducts most of its research in Canada, is owned by Privateer Holdings, the world’s first equity firm that exclusively invests in the emerging legal cannabis field and marijuana-related businesses. Privateer CEO and Co-founder, Brendan Kennedy, told The Huffington Post Australia the trial will have global significance, with cannabis still subject to prohibitive classifications in parts of the United States.

Read more in Huffington Post Australia